Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe page no longer lists the condition 'Multiple myeloma' and removes the related topic 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- A consolidated Locations section now lists New Jersey and New York sites, replacing the prior separate New Jersey Locations and New York Locations sections. The page revision has been updated to v3.3.3.SummaryDifference0.3%

- Check46 days agoChange DetectedThe page footer now displays 'Revision: v3.3.2' and the previous 'Revision: v3.2.0' label is removed.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page removed the general government funding/operating status notice at the top. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedAdded the label 'Last Update Posted (Estimated)'. Removed the label 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedMedlinePlus Genetics related topics: Multiple myeloma was added to the page's related topics section.SummaryDifference0.9%

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.